Desmopressin and type II B von Willebrand disease

Haemophilia

Volumn 2, Issue 2, 1996, Pages 73-77

  Castaman, G ^a   Rodeghiero, F ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Bleeding time; Desmopressin; Inherited bleeding disorders; Type 2 B v WD; von Willebrand disease; von Willebrand factor

Indexed keywords

DESMOPRESSIN; GLYCOPROTEIN IB; NEUROHYPOPHYSIS HORMONE; RISTOCETIN; VON WILLEBRAND FACTOR;

BLEEDING; BLEEDING TIME; CLINICAL TRIAL; CONCENTRATION RESPONSE; DRUG EFFICACY; HUMAN; META ANALYSIS; MOLECULAR WEIGHT; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR AFFINITY; SHORT SURVEY; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TOOTH EXTRACTION; VON WILLEBRAND DISEASE;

EID: 0029967568     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.1996.tb00018.x     Document Type: Short Survey

References (24)

1. Rodeghiero F, Castaman G, Mannucci PM. Clinical indication for desmopressin (DDAVP) in congenital and acquired von Willebrand disease. Blood Rev., 1991; 5: 155-61.
2. Sadley JE. A revised classification of von Willebrand disease. Thromb Haemostas, 1994; 71: 520-4.
3. Ruggeri ZM, Zimmerman TS. von Willebrand factor and von Willebrand disease. Blood, 1987; 70: 895-907.
4. Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med, 1980; 302: 1047-51.
5. Ruggeri ZM, Zimmerman TS. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platefets. J Clin Invest, 1980; 65: 131-25.
6. Weiss HJ, Sussman II. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers. Blood, 1986; 68: 149-56.
7. Holmberg L, Berntorp E, Donner M, Nilsson IM. von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma. Blood, 1986; 69: 668-72.
8. Holmberg L, Dent JA, Schneppenheim R, Budde U, Ware J, Ruggeri ZM. von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure. J Clin Invest, 1993; 91: 2169-77.
9. Ginsburg D, Sadler JE. von Willebrand disease: a database of point mutations, insertions, and deletions. Thromb Haemostas, 1993; 69: 177-84.
10. Holmberg L, Nilsson IM, Borge L, Gunnarsson M, Sjorin E. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type IIB von Willebrand's disease. N Engl J Med, 1983; 309: 816-21.
11. Takahashi H, Nagayama R, Hattori A, Shibata A. Platelet aggergation induced by DDAVP in platelet-type von Willebrand's disease. N Engl J Med, 1984; 310: 722-3.
12. Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma JP, Vicic WJ, Rogers J. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med, 1982; 306: 326-33.
13. Castaman G, Rodeghiero F, Lattuada A, Mannucci PM. Desmopressin-induced thrombocytopenia in type I platelet discordant von Willebrand disease. Am J Hematol, 1993; 43: 5-9.
14. Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, Zimmerman TS. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes. Blood, 1982; 59: 1272-8.
15. Sakariassen KS, Cattaneo M, van den Berg A, Ruggeri ZM, Mannucci PM, Sixma JJ. DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood, 1984; 64: 219-36.
16. De la Fuente B, Kasper CK, Rickles FR, Hoyer LW. Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin. Ann Intern Med, 1985; 103: 6-14.
17. Kyrie PA, Niessner H, Dent J, Panzer S, Brenner B, Zimmerman TS, Lechner K. IIB von Willebrand's disease: pathogenetic and therapeutic studies. Br J Haematol, 1988; 69: 55-9.
18. Casonato A, Fabris F, Girolami A. Platelet aggregation and pseudothrombocytopenia induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type IIB von Willebrand's disease. Eur J Haematol, 1990; 45: 36-42.
19. Connaghan DG, Gralnick HR. Beneficial response to desmopressin in type IIB von Willebrand's disease. Blood, 1990; 76: 417 (abstract).
20. Casonato A, Pontara E, Dannhauser D, Bertomoro A, Sartori MT, Zerbinati P, Girolami A. Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease. Blood Coagul Fibrinol, 1994; 5: 959-64.
21. Gralnick HR, Williams SB, McKeown LP, Rick ME, Maisonneuve P, Jenneau C, Sultan Y. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal von Willebrand factor. J Clin Invest, 1985; 76: 1522-9.
22. Saba HI, Saba SR, Dent J, Ruggeri ZM, Zimmerman TS. Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia circulating platelet aggregates, and spontaneous platelet aggregation. Blood, 1985; 66: 282-6.
23. Mannucci PM, Ruggeri ZM, Pareti Fl, Capitanio A. DDAVP in haemophilia. Lancet, 1977; 2: 1171-2.
24. Fowler WE, Berkowitz LR, Roberts HR. DDAVP for type II B von Willebrand's disease. Blood, 1989; 74: 1859-60.